Location: Home
  • search
  • go
  • Relate News
  • 5/13/2026Strategic Partnerships Redefine China's Biotech Innovation Model: CBPF
  • 5/12/2026BMS Strikes Up to $15.2B Hengrui Alliance to Accelerate Global Drug De...
  • 5/12/2026China Holds National Healthcare Reform Meeting, Prioritizes Public Hos...
  • 5/12/2026China Moves to Expand Maternity Insurance Coverage and Birth-Related B...
  • 5/12/2026BrightGene Reports Phase 3 Success for Dual GLP-1/GIP Obesity Drug BGM...
  • 5/11/2026NHC Seeks Comments on Revised Human Genetic Resources Regulation Imple...
  • 5/11/2026CDE Releases Draft MSC Stem Cell Product Guideline for Public Consulta...
  • 5/8/2026Viatris Tops Quarterly Estimates on Strong China Performance and Brand...
  • 5/8/2026China Unveils Tougher Nationwide Rules Governing Medical Representativ...
  • 5/8/2026Recent Executive Moves
  • 5/7/2026Amgen Wins China Approval for Evenity (Romosozumab)
  • 5/7/2026Novo Nordisk Signals Delays for Ozempic Generics in China Despite Pate...
  • 5/7/2026Sino Biopharm Wins China Approval for World's First CDK2/4/6 Inhibitor...
  • 5/6/2026NHSA Solicits Comments on National Body Part Coding System to Strength...
  • 5/5/2026UCB's $2.2B Candid Deal Highlights China-Origin Innovation Flowing Int...
  • 5/5/2026Bambusa Completes Enrollment in Mid-Stage Trial of Bispecific Antibody...
  • 5/5/2026China Tightens Biopharma Supply Chain Controls, Raising Stakes for MNC...
  • 5/5/2026Gyre Thera Closes $300M Cullgen Deal
  • 5/5/2026A Strategic Playbook for Chinese Biotech Cross-Border Deals: Navigatin...
  • 5/1/2026A Biopharmaceutical Superpower: China's Rise, Its Limits, and What Com...
  • 5/1/2026China Pharma Trade Rises 4.22% in Q1 as Exports Shift Toward High-Valu...
  • 5/1/2026China Approves Two Innovative Homegrown Therapies Ahead of Holiday Bre...
  • 5/1/2026EU Approves Henlius–Organon Pertuzumab Biosimilar POHERDY
  • 5/1/2026Shanghai Pharma Completes Exit from Sino-US JV with $140M Stake Sale t...
  • 5/1/2026Recent Official and Executive Moves
  • 4/30/2026Livzon Takes Control of Vietnam's Imexpharm in $228M Deal
  • 4/29/2026Mabwell Lists in Hong Kong in First "A-to-H 18A" Biotech Debut
  • 4/29/2026AstraZeneca Secures Dual First-Line Liver Cancer Approvals in China fo...
  • 4/29/2026Samsung Bioepis Expands into China with ATLATL Partnership to Boost In...
  • 4/29/2026From fast follower to originator: How Asia is rewiring biopharma innov...
  • Page:1/386 Total number of articles:11579: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group